NetworkNewsBreaks – ABcann Global Corp. (TSX.V:
Post# of 111
Pharmaceutical-grade cannabis company ABcann Global Corp. (TSX.V: ABCN) (OTCQB: ABCCF) this morning issued a business update. “Over the past two quarters, we have enhanced our leadership team, strengthened our balance sheet, improved operational effectiveness, and made significant commercial advancements,” Barry Fishman, CEO of ABcann, stated in the news release. “ABcann is well-positioned, with approximately $130 million in cash, to accelerate the growth of our business.” Per the update, the company’s management team has formulated a growth strategy for 2018 that is focused on several key areas, including expansion of its production capacity, a go-to-market strategy that centers on rebranding the company and introducing new consumer brands, international expansion initiatives in both Australia and Europe, a coordinated R&D program and heightened organizational effectiveness through the strengthening of its leadership team.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer